Close
CDMO Safety Testing 2026
Novotech

Press Releases

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that partner SK bioscience has received expanded manufacturing and marketing approval from the Korean Ministry of Food and Drug Safety (KMFDS) for...

Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies

Cryoport, Inc.,a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences industry focused on the pharmaceutical and cell and gene therapy markets, today announced a new strategic partnership with Syneos Healthยฎย (NASDAQ: SYNH), the only fully...

Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance

Charles River Laboratories International, Inc. and Rznomics Inc., a South Korea-based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced a viral vector contract development and manufacturing organization (CDMO) partnership. Rznomics will leverage Charles Riverโ€™s viral vector...

New IDC at Pharmapack: Airnov’s latest innovation to be on display to the world at upcoming event

Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, has launched a brand-new advanced solution which promises to provide substantial benefits to the pharmaceutical industry. IDCยฎ (Integrated Desiccant Closure), enables manufacturers to reduce the number of components that would...

Abzena hires Matthew Stober to lead the company through the next phase of global growth

Abzena, the leading end-to-end integrated CDMO for Antibody Drug Conjugates (ADCs) and complex biologic molecules, announced that Matthew Stober has joined as their new Chief Executive Officer. Matthew Stober was most recently CEO of therapeutic companies CastleVax and Istari Oncology.ย ...

Novotech Acquires US-based Drug Development Consulting Firm, CBR International

Novotech, the leading Asia Pacific-centered biotech CRO announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group. CBR was founded in 2002 as a consultancy company focused on assisting biotechnology and pharma companies...

Novotech Acquires European CRO, Strengthens Global Operations

Novotech announced the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent. The acquisition is part of Novotech's global expansion program. EastHORN was established in 2004 and has...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป